Related Experiment Video
Updated: Aug 28, 2025

Use of a Hanging-weight System for Liver Ischemia in Mice
Published on: August 7, 2012
Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure
Yang Cao1, Yuchen Wang1, Zhenqi Zhou2
1Department of Medicine, Division of Cardiology, University of California, Los Angeles, CA 90095, USA.
Abstract:
Tissue-tissue communication by endocrine factors is a vital mechanism for physiologic homeostasis. A systems genetics analysis of transcriptomic and functional data from a cohort of diverse, inbred strains of mice predicted that coagulation factor XI (FXI), a liver-derived protein, protects against diastolic dysfunction, a key trait of heart failure with preserved ejection fraction. This was confirmed using gain- and loss-of-function studies, and FXI was found to activate the bone morphogenetic protein (BMP)-SMAD1/5 pathway in the heart. The proteolytic activity of FXI is required for the cleavage and activation of extracellular matrix-associated BMP7 in the heart, thus inhibiting genes involved in inflammation and fibrosis. Our results reveal a protective role of FXI in heart injury that is distinct from its role in coagulation.
Related Concept Videos
Heart Failure II: Pathophysiology
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pathophysiology of Heart Failure
Heart Failure VI: Adjunct Therapies
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

